You are here

BRCA2

BioMarin sells its PhIII cancer drug to Medivation for $570M

Fierce Biotech

Mon, 08/24/15 - 11:22 am

Quest Introduces Breast-Cancer Gene Test Rivaling Myriad

Bloomberg

Wed, 10/16/13 - 08:32 am

Quest Diagnostics

Myriad Genetics

Court Allows Patents On Breast Cancer Genes

Pharmalot

Mon, 08/1/11 - 10:28 am

Myriad Genetics